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Abstract (250 words) 
 Manuscript word count:  4445 words total. 
Abstract:    249 words  
Body of article: 4191 
ABSTRACT: 
BACKGROUND: Valid and reliable tools to assess lymphedema are necessary to accurately 
evaluate status and to objectively document and measure the results of interventions. 
Understanding the advantages and disadvantages of each measure can inform the clinician’s 
choice of the appropriate tool to be used in the clinic or research setting. PURPOSE: To identify 
reliable and valid measurement techniques which are sensitive to change for assessing edema 
volume or soft tissue change in the lower extremities or genital region of patients with 
lymphedema. METHODS: A systematic review of the literature was conducted to assess the 
published psychometric properties and clinical feasibility of each method identified. Task Force 
members independently reviewed each measure using the Cancer EDGE Rating Form. 
RESULTS:  Water displacement and circumferential measurement methods by tape measure 
were both rated as Highly Recommended to quantify lower extremity limb volume. Water 
displacement was determined to be the gold standard by which all other assessments of volume 
are benchmarked. Optoelectric volumetry and bioelectric impedance analysis were both rated as 
Recommended, and ultrasound was rated Not Recommended.  CONCLUSION:  The Urogenital 
Cancer EDGE Task Force highly recommends water displacement and circumferential tape 
measurement for use as reliable methods for assessment and documentation of change of limb 
volume in this patient population. Early detection of subclinical lower extremity lymphedema in 
this patient population remains challenging as there is no ‘index’ limb that can be proven to be 
3 
 
uninvolved in a patient population with documented pelvic node dissection/irradiation.  No 
articles were found to support valid and reliable genital lymphedema volume measurement. 
KEYWORDS:  Psychometrics, measurement, limb volume, edema, urogenital neoplasms  
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INTRODUCTION: 
Urogenital cancers impact over 5 million Americans, with an estimated 426,000 new 
cases annually.1 Urogenital cancers typically affect the urinary system (kidney and related 
anatomy, bladder) or the genitals (including ovaries, uterus, cervix, testis, vulva, prostate, and 
penis). Mortality estimates for 2017 are approximately 90,000 individuals, with five-year 
survival rates ranging from 68% for all stages of cervical cancers, to 99% for all stages of 
prostate cancers.2  The magnitude of impact of effective treatments on life expectancy suggests 
that these individuals will live for many years after a cancer diagnosis. It is therefore important 
that ongoing monitoring of late and long-term effects of cancer treatment take place to help these 
individuals return to the level of function and quality of life prior to the cancer diagnosis. 
 Most urogenital cancers are treated with some combination of surgery, radiation, and 
chemotherapy. Surgeries range from removal of the involved organ (oophorectomy, 
hysterectomy, prostatectomy, etc.), and often involve pelvic lymph node dissection to determine 
the extent of cancer. Radiation to either the tumor bed and/or the groin lymph nodes impacts the 
tissues treated as well, with well documented radiation fibrosis resulting from treatment further 
compromising the pelvic/groin lymphatic flow.3  The incidence of lymphedema of the lower 
extremities and groin varies from 21-36%4,5 among women surgically treated for endometrial, 
cervical, or ovarian cancer, and 34% among a mixed population of urogenital cancers.6 The 
development of lymphedema of the lower extremities and genitalia results in both functional 
impairments and marked decline in quality of life. In a study investigating the prevalence of 
symptoms associated with lower limb lymphedema, all of participants with lymphedema 
reported difficulty walking, and more than 75% reported achiness and pain.6 Furthermore, 
among a population of individuals with lower extremity lymphedema, participants’ baseline 
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quality of life scores on the 36-Item Short Form Survey (SF-36) were approximately 20% lower 
than that of a healthy population.7,8  The presence of lower extremity lymphedema negatively 
impacts both functional abilities and quality of life, and the need to identify and manage this 
chronic disease is clear in order to mitigate these negative effects. 
 While no universally accepted standards exist to clinically diagnose the presence of 
lymphedema, evidence exists to guide this clinical judgement.  Typically, a clinical diagnosis of 
lymphedema is based on a difference in limb volume, either from a baseline measure or in 
comparison to a contralateral limb.  The International Society of Lymphology (ISL), in their 
2016 Consensus Document on the Diagnosis and Treatment of Peripheral Lymphedema, 
identifies a multi-stage classification system for lymphedema:  Stage 0 is subclinical, such that 
while some symptoms of heaviness, achiness, or sense of tightness are felt by the individual, the 
lymphedema is not visible;  Stage I is early lymphoma that reverses with elevation; Stage II 
manifests pitting without reversal with elevation; and Stage III is considered lymphostatic 
elephantitis.9  Furthermore, the ISL Consensus Document suggests that minimal change is 
greater than 5% but less than 20%, moderate is 20-40%, and severe is greater than 40%.9  Other 
evidence suggests that preclinical lymphedema is characterized by a 3-5% difference in limb 
volume, while a 5% difference is considered indicative of early lymphedema.10,11  Still others 
have used differences of 10%, 200 ml, or 2cm of circumference as the onset of lymphedema.12  
The monitoring of limb volume change is the most common method to identify lymphedema and 
its earliest development, although indirect methods of measuring lymphedema are also 
employed. Most direct limb volume measurements are completed using water displacement, tape 
measure circumferential measurement, or optoelectric volumetry, while indirect measures 
include bioelectrical impedance analysis or ultrasound. 
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 Accurate assessment of an individual is critical to identify impairments which 
drive rehabilitation treatment decisions and to monitor effectiveness of interventions. Following 
a call by Rebecca Craik in the 2005 McMillan lecture that the profession of physical therapy 
agree on the best outcome measures, the American Physical Therapy Association (APTA) 
Section on Research advocated for the determination of a core set of valid and reliable 
measurement tools. The identification of and support for particular tools are incorporated into the 
Evidence Database to Guide Effectiveness (EDGE). The Neurology Section (now the Academy 
of Neurological Physical Therapy) led the inaugural reviews of outcomes measures for stroke, 
traumatic brain injury, and multiple sclerosis populations. These reviews used a four-point 
ranking scale from Highly Recommended to Not Recommended. The Oncology Section adopted 
the procedures of the Neurology EDGE task forces, modifying the ranking scale to five levels, 
expanding the definition of “Unable to Recommend” (Figure 1).13 To date, the Oncology Section 
has completed 14 reviews in breast cancer, three reviews in prostate cancer, five reviews in head 
and neck cancer, and one review in colon cancer. In 2016, the Academy of Neurologic Physical 
Therapy modified the ranking scale, and the Oncology Section adopted the new scale (Figure 2) 
for reviews going forward.14 While this review was completed prior to the adoption of the new 
rating scale, the original rankings determined by the task force remain consistent with the new 
ratings. In light of the need to identify a core set of outcome measures for lymphedema among 
the urogenital cancer population, the purpose of this systematic review is to identify reliable, 
valid, responsive, and clinically feasible methods to measure lower limb and genital 
lymphedema.  
METHODS 
Search Strategy 
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The authors conducted a systematic review of methods and tools to clinically measure lower 
extremity limb and genital lymphedema in urogenital cancers in order to identify reliable, valid, 
and clinically feasible methods to employ in daily practice. The primary literature search took 
place August through September 2015 using six electronic databases: Google Scholar, 
PubMed/Medline, CINAHL, Web of Science, Cochrane Review, and PEDro. Primary search 
terms that were used included: lymphedema, lower extremity, limb volume, measurement of 
limb volume, and genital lymphedema. Additional search terms that described the measurement 
of lower extremity limb volume and lymphedema, and genital lymphedema in addition to the 
names of specific clinical measuring tools can be found in Appendix A. Secondary searches 
through bibliographic review of oncology journals and key research articles took place between 
October and December 2015.  
Article Selection 
To be included in this review, studies (1) were published in English; (2) clinically measured limb 
volume by direct or indirect means preferably of the lower extremity, and/or genital 
lymphedema; (3) reported psychometric properties; (4) presented methods considered clinically 
feasible in a typical physical therapy practice; and (5) included adults (≥ 18 years). Measures 
which are not available to the physical therapist, such as lymphoscintography, fluorescence 
lymphography, or magnetic resonance imaging, were not included. Additionally, self-reported 
measures of measuring lymphedema were not included, as this review is focused specifically on 
objective clinical measures. Included articles were considered if published from January 1, 1996 
– present, unless a study published prior to 1996 was deemed a key article.   Research focusing 
on participants with lower extremity or genital lymphedema as a result of urogenital cancers took 
first priority, followed by upper extremity lymphedema and/or vascular disorders and venous 
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insufficiency. While searching the databases, when other patient populations in which limb 
volume measurements were investigated, such as  lower extremity amputations, met all other 
inclusion criteria, these articles were included when no other evidence in the cancer population 
was available.   While it may appear that the research in upper extremity lymphedema, vascular 
disorders or venous insufficiency, and residual limbs are not applicable to this review, the 
methods of volume measurement, whether water displacement or use of a truncated cone, are 
based in principles of physics and mathematics and do not change based on the item measured.  
After retrieving all articles, duplicates were removed, and studies were screened on the basis of 
title and abstract initially, followed by review of full-text. 
Data Extraction and Analysis  
Teams of two reviewers independently performed data extraction using the Cancer EDGE Task 
Force Rating Form (available online). Psychometrics included in the Cancer EDGE Task Force 
Rating Form consisted of reliability, validity, ceiling/floor effects, sensitivity to change, and 
clinical utility. The following criteria were applied to determine the strength of the psychometric 
properties: excellent reliability = >0.90; good reliability = 0.76-0.89; moderate reliability = 0.50-
0.75; and poor reliability <0.50.15  Concurrent, discriminative, criterion-related, and construct 
validity values are reported when available, as well as measures assessing responsiveness to 
change such as minimal detectable change (MDC) and minimal clinically important difference 
(MCID). In the absence of these common statistical calculations, the coefficient of variation was 
reported.  Determining clinical usefulness was based on equipment needed, cost, ease of use, 
scoring/interpretation, and availability of normative data.  Outcome measures that directly or 
indirectly measured lower extremity and genital lymphedema were categorized into one of five 
tools: (1) Water Displacement, (2) Tape Measure, (3) Optoelectric Volumetry, (4) 
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Bioimpedence, and (5) Ultrasound. Each reviewer then rated the measure using the original 
Cancer EDGE Rating Scale. Any discrepancies in ratings were discussed with all four reviewers 
until consensus was obtained.  
RESULTS:   
The initial literature search using terms outlined in Appendix A, alone or in combination, 
yielded 181,658 articles. After screening for titles and abstracts and removing any duplicates, 66 
articles were identified for subsequent review. An additional eight studies were found on 
secondary search. No articles were found that met eligibility criteria for measurement of genital 
lymphedema.  After applying inclusion/exclusion criteria (articles were removed which did not 
have psychometric properties of interest, or were not published in the date range specified, or 
were not conducted within populations previously identified), a total of 33 articles were 
reviewed.   Some of the studies included psychometric analysis of more than one measure of 
lymphedema such that the number of articles reviewed for each tool is not mutually exclusive. 
The numbers reviewed by category are:   Water Displacement (11), Tape Measure (15), 
Optoelectric Volumetry (6), Bioimpedence (12), and Ultrasound (1). Figure 3 outlines the flow 
diagram for the literature search.  
The outcome measures, ratings, and strengths and weaknesses are summarized in Table 
1, while Table 2 presents the psychometric properties of the Highly Recommended and 
Recommended measures for measurement of lower extremity lymphedema. Lastly, Table 3 
summarizes the clinical usefulness of the recommended measures for lower leg lymphedema.  
Water displacement and tape measure circumferential measurement methods scored a 4, 
and are Highly Recommended by the EDGE Task Force on Urogenital Cancers. Both measures 
have been extensively tested and used to measure limb volume in persons with lower extremity 
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edema or lymphedema. Two other measures, optoelectric volumetry and bioimpedance, are rated 
3, or Recommended, based on limitations in clinical utility. The use of ultrasound was not 
recommended (rating of 1) as a measure of lower extremity lymphedema due to a lack of 
available psychometric evidence for use and poor clinical utility. Furthermore, no clinical 
method can be recommended to measure genital lymphedema as measures reported on in the 
literature are limited to lymphangiography and magnetic resonance lymphography.  
DISCUSSION 
Based on the chronic nature of lymphedema, the accurate and reliable assessment of limb 
volume is crucial to detect lymphedema, and to monitor change in limb volume or amount of 
lymphedema over time. As lymphedema may not be visibly apparent in its earliest stages, 
ongoing monitoring of the limb at risk is important to detect any change over time. Limb volume 
as changes as small as 3% have been documented as pre-clinical lymphedema in a population of 
women with breast cancer related lymphedema.10 It is reasonable to extrapolate these findings in 
lower extremity lymphedema in the absence of other research support, and support the need to 
continue to monitor the limb at risk. Direct or indirect measures of lymphedema (limb volume or 
impedance ratios) can be recorded at baseline prior to medical intervention, and used in 
comparison to a contralateral normal limb, if available, or the same limb over time, to assess and 
track the response to treatment. Long term, measurements allow for monitoring of the success of 
the self-management skills which the individual employs.  Water displacement, circumferential 
measurement with a tape measure, optoelectric volumetry, and bioelectrical impedance analysis 
are recommended tools to monitor lower extremity limb volume.  While the research available 
lacks specific data indicating how responsive each of these measures are, those measures which 
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can accurately detect small levels of change, such as a 3% volume change or a difference in 
impedance ratios between limbs, are indicated for use to monitor change in this population.  . 
Water Displacement 
Water displacement is a method for assessing volume used since first described by Archimedes 
in Ancient Greece. Archimedes Principle, a body submersed in a liquid loses weight equal to that 
of the volume of liquid that it displaces, provides the basis for limb volume measurement in 
water.16 Water displacement as a method to calculate the volume of a limb is reproducible using 
a standardized container, standardized temperature of the water and room, standardized 
immersion of the limb at the same depth and position, and a standardized way to measure the 
displaced water.17,18 Measuring displaced water is most often done by volume, including the use 
of a transducer equipped volumeter, although some studies used the weight of the displaced 
water.17,18 In either method, the involved limb is submerged in a container of water, generally a 
volumeter, in the same position and to the same depth on each measurement occasion. Limb 
volume is then based on the measurement of the water displaced. 
Water displacement is considered the ‘gold standard’ of volume measurement to which 
all other methods are compared.19 Most studies reviewed which described the use of water 
displacement measured volumes to the level of the knee, and were done in patients with venous 
insufficiency or peripheral vascular disease.17,18 There were no studies found for full leg water 
displacement, most likely reflecting the difficulty that would be encountered in creating a 
container for volumetric measurement of differing length legs and the attendant difficulty in 
achieving insertion of a full leg into the device. Water displacement was found to have a high 
day to day reliability in repeated measures done over five episodes. Test-retest values ranged 
from r=.95-.99, and the mean percent change in volume measurements ranged between 0- 
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.37%.16 Overall inter-rater reliability of this method varies from ρ=0.95, where ρ is the 
intrasubject correlation coefficient, based on an analysis of variance,20 to ICC=0.99.21 One study 
examined the minimum percent change of the volume of the leg and determined the MDC to be 
22.2-23.4%.22 These excellent psychometric properties make water displacement a Highly 
Recommended measure of lower extremity limb volume. 
The advantages of water displacement as a method for volume assessment are low cost 
(generally less than $400) with high accuracy in assessing the most distal portion of the limb.19 
Volumeters are generally made of plexiglass with a spout and come with a calibrated cylinder 
collecting vessel. High clinical feasibility, however, may be hindered by the time investment to 
measure (filling, draining, cleaning), the potential excess size of a limb not fitting a volumeter, 
and the inability to measure the full limb to the groin. 
It should be noted that a contraindication to using water displacement is the immersion of 
limbs with open wounds. A compelling reason for the importance of infectious disease 
precautions is due to the fact that those with lymphedema have a known compromise in their 
immune response with a greater risk of cellulitis.23 Another limitation in the use of volumeters 
for individuals with lower extremity lymphedema is the possibility of an excessive size of the 
patient’s leg. It is not unusual in some clinical settings to see patients with calf circumferences in 
excess of 120 cm, far exceeding the size of volumeters that are available commercially.  
Circumferential Measurement by Tape Measure 
Taking circumferential measurements at regular intervals with a non-elastic tape measure 
is the most widely used clinical method to determine the presence of lymphedema and assess 
volume changes when monitoring response to treatment. The best tape measures have several 
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important attributes: are made of non-stretch material, are easily cleaned with alcohol swabs, and 
have clearly and easily discernible markings and an easily seen zero mark. The need for 
consistent tensioning of the tape can be addressed by the use of a tape measure with a spring 
tension gauge at the zero end assuring the exact same pull with each application. However, 
studies done of circumferential measurement without the use of this tension gauge have 
demonstrated good inter- (ICC=0.97) and intrarater reliability (ICC=0.92-0.99) in both upper and 
lower limb measurement.24,25 
Reliable and reproducible measurements require a standardized positioning of the patient 
and establishment of reproducible landmarks for marking intervals of measurement. It is 
important to utilize a straight measure of intervals marked for measurement rather than a 
contoured laying on of the tape on the limb as the contour of an abnormally shaped 
lymphedematous limb can change dramatically during treatment and lead to errors in subsequent 
markings of intervals for repeated measurement. Boards with a footplate provide this rigid 
straight method to mark intervals more consistently.  Landmarks for the zero interval also 
improve the reliability of the resultant and subsequent measurements. In several studies, the 
landmark chosen is the malleoli ,17-19 while in others26,27 the heel is the landmark. In practice, the 
malleoli can be almost obliterated in the lymphedema patient at evaluation, so that a base of heel 
or distance from the floor (the footplate) to the bend of the ankle is least likely to change with 
treatment and should be used as the zero interval.28 The distance between intervals varies 
depending on the study; 4 cm and 10 cm intervals are reported.17,27,29 Both methods are reliable 
and valid, and correlate highly with each other (r>.99) however, the 4 cm method may better 
account for abnormal lobules in advanced lymphedema.24,29 Whichever interval is used for 
measurement, values are typically entered into an appropriate truncated cone formula to 
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determine limb volume. The Frustrum or truncated cone formula is more accurate in assessing 
limb volume than a cylinder formula, as the limb is roughly the shape of a cone.30   
The advantages of using a tape measure for volume measurement are cost (low) and 
accessibility (high) in the clinical setting. This measurement can also be done even if the patient 
has wounds or is unable to assume a standardized position for measurement by water 
displacement. When compared to the gold standard water displacement, the validity is excellent, 
(ICC=0.93 – 0.98), except in grade 1 edema where the correlation between measures was 
moderate (r=0.45).17,26,27 Reliability is also excellent: test-retest reliability in a 1-2 week 
timeframe was excellent (ICC=0.94) and good (ICC=0.82) long term; interrater and interrater 
reliability were both excellent (ICC=0.89-0.99 and ICC=0.82-99, respectively).19 Minimal 
ceiling or floor effects are present using a tape measure measurement, however one study 
reported that when the leg volume difference is >11%, tape measurement overestimated the 
volume difference as compared to water displacement.17 One study examined the SEM and 
determined this to approximately 84 ml or 0.64% of lower leg volume.31  These sound 
psychometric properties and high clinical utility make this tool highly recommended by the 
EDGE task force. 
The disadvantage of tape measurement method is time needed for multiple measurements 
and then calculation for comparison with contralateral ‘normal’ limb or for comparison to pre-
treatment volumes. The time to calculate volume can be mitigated through the use of previously 
formatted spreadsheets such that simply entering circumferential values will render total volume 
and percent volume difference. Of clinical importance is the consideration that in lower 
extremity lymphedema, the lymphatic compromise is often bilateral despite presentation of 
swelling in only one limb. Post treatment measurements often demonstrate a volume reduction in 
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what was thought to be a ‘normal’ limb due to the focus in Complete Decongestive Therapy 
(CDT) on the proximal, intact lymphatic system. This is consistent with the physiological fact 
that there needs to be an increase of 20-30% in the normal interstitial volume before it is 
clinically apparent.32 Therefore, comparison over time may be a more clinically relevant 
measure. 
Optoelectric Volumetry 
Optoelectric volumetry, or perometery, is an assessment of limb volume that utilizes an 
array of infrared beams oriented via a square frame at right angles to each other.  As the frame, 
tracking on a carriage, is passed over a limb in either a horizontal or vertical configuration, the 
limb volume is calculated using a computerized algorithm. The validity of optoelectric 
volumetry was established in comparison to water displacement and ranges from r=0.97-0.99.33-
35 Test-retest reliability is excellent with an ICC=0.99.18,36  Intrarater reliability is reported as 
excellent, with an ICC≥0.99.37,38 The repeated measures coefficient of variation was reported as 
0.13.36 
The advantage of optoelectric volumetry is that a highly accurate limb volume can be 
calculated very quickly once the equipment is on and ready for use. For the commercially 
available Perometer, additional benefits include optional compression garment measurement as 
the software reports the actual circumference at the standardized landmarks used by German 
manufacturers for garment manufacturing.  
The main disadvantages to the Perometer being used in the clinical setting are the cost 
and size of the equipment. The equipment is large, requiring approximately half of the size of a 
typical treatment room. The purchase price in 2015 was $16,000-26,000 USD, with one primary 
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manufacturer: Pero-System GmbH in Germany (Wuppertal, Germany).  Whether to utilize a 
horizontal or a vertical system is dependent on the primary population to be measured. Although 
either unit can measure both upper extremity and lower extremity, a horizontal unit requires that 
the mid-frame be positioned at chair height for the lower extremity while the individual must 
bend over to measure the upper extremity in a vertical unit. The size of the frame limits the 
extent to which the unit can traverse proximally up the limb and reduces the volume calculation 
possible for the limb. Accuracy of the measurements depend on correct horizontal positioning of 
the limb and patients with limited range of motion may not be able to be correctly 
positioned.34,35,37  Newer optoelectric volumetry units, such as that designed by Skanlab, are 
being developed for clincial use.39 It is possible that other optoelectric volumeter units may be 
available commercially in the future. 
Bioelectrical Impedance Analysis 
Multi-frequency bioelectrical impedance analysis (BIA) is a non-invasive assessment 
technique that utilizes a very small alternating current which is passed through tissue creating a 
measure of impedance, or resistance to flow of the current. The current moves through the path 
of least resistance in the tissues measuring the resistance through the water content of the 
intracellular and extracellular portions of the soft tissue. Low frequency current passes through 
the extracellular fluid, while high frequency current passes through the intracellular fluid.  BIA 
then measures both total resistance and the resistance of the extracellular fluid quantify the 
impedance. This resistance is compared to an unaffected limb, creating an impedance ratio.22 
Originally tested in women with breast cancer-related lymphedema, if this inter limb impedance 
ratio exceeds the mean ratio plus three standard deviations, a diagnosis of lymphedema is 
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confirmed.40,41 Like other methods of volume assessment, pre-operative values for comparison 
post-surgery are helpful for early diagnosis.40 
Bioimpedance devices utilize four or eight electrode arrays; the eight electrode systems 
are considered to be more accurate.42 Recommendations for reproducibility included: taking 
measurements at the same time with a constant ambient temperature, and cleaning the sites with 
alcohol or wet wipes before standardized application of the electrodes.41,42 In a study comparing 
bioelectrical impedance values between individuals diagnosed with lymphedema via 
lymphoscintography and controls, BIA accurately identified those with lymphedema.43  Intra-
tester reliability ICC=0.88 in a population with lymphedema due to filariasis.44 The predictive 
value of BIA was 53.2% in this same population.44 The sensitivity of BIA to monitor change was 
excellent in two studies: 100% sensitivity is reported in a population with lymphatic filariasis, 
and treatment differences compared to baseline were highly significant (p<.001) in patients with 
pedal edema.22,44 
The most prominent advantage of BIA is that it can detect the onset of lymphedema 
before clinical signs of swelling become apparent.40 It can be completed in 5-15 min depending 
on the number of repeated measures made and is an accessible technology for pre-operative 
values for reference in the post-operative period. A reference range has been established for the 
impedance ratio for the legs without pathology, allowing for criteria for the diagnosis of early 
lymphedema in the leg.41  
The disadvantages of BIA are that it remains an assessment that, with the current 
bioelectrical impedance protocol which creates a ratio comparing the unaffected and affected 
limb, is useful only for unilateral lymphedema risk.41 In most urogenital cancers, pelvic lymph 
node dissection and/or radiation affects the lymphatic drainage patterns of both lower extremities 
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even in a patient who presents with unilateral swelling. Another disadvantage of BIA is that it is 
useful primarily for the assessment of early stage (0-1) lymphedemas, as in the later stages of 
lymphedema the extracellular fluid has been replaced to a large degree by fibrous tissue.45 When 
this has occurred, BIA is not helpful for diagnosis or monitoring of change over time. Lastly, the 
electrodes are single use and therefore have a cost associated with each use.  
Considerations in measuring limb volume 
Two cautionary issues arise when monitoring the lower limb at risk in urogenital cancer.  
First, there is a significant difference in volume assessments in the lower extremity when the 
entire limb is included in the measurements since the majority of swelling is often only below the 
knee.27 The length of the limb being measured, whether to the knee as is typical in water 
displacement, or to the groin including the thigh, can also impact accuracy and interpretation. 
Specifically, as the amount of change in the smaller lower leg may be only a small percentage of 
the whole limb, the size of the thigh may mask the amount of change of the lower leg.  Rather, 
using clinical judgment incorporating patient symptom report and clinician expertise, the 
measures used should be to the level of greatest involvement. If this is not amenable to water 
displacement, clinical judgment then determines that water displacement should not be used.  
However, if only the lower leg is involved, then this method may be appropriate.  Ideally it is 
clinically important to have measurements of the full thigh pre-treatment because there is also a 
possibility of ‘fluid shift’ into the proximal limb or genitals during treatment which must be 
recognized and addressed, and this is most easily accomplished via circumferential 
measurements with a tape measure. 
The second consideration is the possibility of bilateral lower limb involvement because 
this limits the usefulness of limb to limb comparisons.  For this reason, it is essential that 
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baseline measures are taken prior to medical intervention.  The Prospective Surveillance Model 
developed for women with breast cancer includes baseline assessment and ongoing periodic 
monitoring.46 This model could easily be adopted for use in the urogenital population.  These 
baseline measures, then, would serve as a comparison for any changes in the lower limbs. 
Ultrasound is not recommended by the urogenital cancer EDGE Task Force. The limited 
psychometric properties, in conjunction with decreased clinical utility, particularly cost and 
training, do not support its use for assessment of limb volume in this population.  In a study 
examining the diagnostic validity of ultrasound, skin thickness was greater in the involved limb 
compared to the non-involved limb (p<0.05) among women with breast cancer related 
lymphedema,47,48 yet examining the ability to detect change over time was poor as the change in 
skin thickness with a decrease in volume was only minimally correlated (r=.37).49 Furthermore, 
no studies examining reliability were found. 
Limitations 
 This topic of lower limb lymphedema in the urogenital cancer population has not been 
studied to the extent seen in secondary lymphedema related to breast cancer.  This resulted in far 
fewer studies in which the population of interest was available. The authors recommend that 
research be focused on accurately measuring lymphedema, whether directly or indirectly, in the 
urogenital cancer population.  Additional research in the development of optoelectric volumetric 
tools is warranted in order for these tools to become more clinical useful. Furthermore, it is 
essential to develop reliable and valid clinical methods to measure genital lymphedema, and as 
this research need is significant, it should be prioritized.   This literature search was completed in 
September of 2015, and therefore any studies published thereafter with psychometric properties 
may not be included in this review.  Newer studies may provide additional information to 
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evaluate these measures, and the use of bioelectrical impedance analysis is a growing in use as 
measurement technique of lymphedema.  We recommend these ratings be reviewed in 
approximately five years as new evidence becomes available.  As lymphedema is a world-wide 
problem, limiting the search to the English language may have resulted in eliminating important 
research published elsewhere.  All recommendations made by this Task Force are issued based 
on the best available evidence at the time of analysis.  The reader is encouraged to employ 
clinical judgment, expertise, and to take into account patient values when implementing these 
recommendations. 
CONCLUSION 
 This systematic review evaluated methods to measure lymphedema in the urogenital 
cancer population, focusing on lower limb edema/lymphedema. Use of water displacement or 
circumferential measures with a tape measure were Highly Recommended by the Urogenital 
Cancer EDGE Task Force. These measures have sound psychometric properties, and high 
clinical feasibility. Further research is needed in valid and reliable methods to measure genital 
lymphedema. 
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Table Legends: 
Table 1.  Summary of Outcome Measures 
Table 2.  Psychometric Properties of Recommended Measures for Lower Extremity 
Lymphedema 
Table 3.  Clinical Usefulness of Recommended Measures 
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Figure Legends: 
Figure 1: Cancer EDGE Rating Scale 
Figure 2: Cancer EDGE Rating Scale, Updated 2016 
Figure 3. PRISMA Flow of literature search. 
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Table 1:  Summary of Outcome Measures 
 
Measure 
EDGE 
Rating Strengths/Weaknesses 
Water Displacement 4 
• Gold standard method to measure volume 
• Valid in multiple populations 
• Inexpensive 
• Inconvenient – requires a wet room 
• Time investment for infection control 
practices 
• Difficult to submerge full lower limb 
Tape Measure 4 
• Inexpensive 
• Accurate 
• Reliable 
• Validated against the gold standard 
Optoelectric volumetry 3 
• Validated against the gold standard 
• Highly accurate 
• Quick 
• Very expensive for clinical use 
• Requires space 
• Not able to acquire as a medical device 
outside of Europe 
Bioelectrical Impedance 3 
• Effective in early determination of volume 
changes 
• Expensive – unit and electrodes 
• Not as useful in later stage lymphedema 
Ultrasound 1 
• High cost 
• High level of training 
• Poor responsiveness 
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Table 3:  Clinical Usefulness of Recommended Measures 
Measure Equipment Needed Cost Ease of Use Scoring/ Interpretation 
Normative 
Data 
Water 
Displacement 
Yes Minimal High Easy No 
Tape Measure Yes Minimal High  Easy No  
Perometer Yes High Moderate  Easy  No  
Bioelectrical 
Impedance 
Yes High High  Easy  Yes  
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Table 2:  Psychometric Properties of Recommended Measures for Lower Extremity Lymphedema  
Measure Test/Re-Test 
Reliability 
(ICC) 
Inter-rater 
Reliability 
(ICC) 
Intra-rater 
Reliability 
(ICC) 
Responsiveness 
to Change 
Validity 
Urogenital Lymphedema Measures – Highly Recommended 
Water 
Displacement 
ICC =  0.97-
0.9816 (leg) 
r = .95-.9916 
(leg) 
 
ICC = 0.94-
0.9820 (arm) 
ICC=0.9921  
(arm) 
 
 
ICC ≥0.9820,24 
(arm)  
CV = 0.72%16 
MDC (leg) = 
22.2 - 23.4%22 
Gold-standard 
 
Effect size (pedal edema): 0.64-0.8522 (leg) 
 
Tape Measure ICC=0.94 (1-2 
weeks) 
ICC =  0.82 
(long term)19 
(leg) 
 
ICC=0.96 (0.92 
-1.00 CI95)50 
(leg) 
 
ICC = 0.91-
0.9725 (leg) 
Short term (1 
week)  
ICC=0.9019 
Medium term 
(2 weeks)  
ICC=0.8919 
(leg) 
Long term (12 
weeks)  
ICC=0.7819 
(leg) 
 
ICC=0.97 - 
0.98 (0.97 – 
1.00 CI95)25,50 
(leg) 
 
ICC = 0.97-
0.9920 (arm) 
 
Short term (1 
week)  
ICC=0.9419 
(leg) 
 
Long term (12 
weeks) 
 ICC=0.8219 
(leg)  
 
ICC=0.99 (0.97 
- 1.00 CI95)25,50 
(leg) 
 
ICC = 0.95 
(0.96-0.99)24,38 
(arm) 
SEM = 83.6 ml or 
.64% (lower limb 
lymphedema)31 
Pearson CC of residual limb’s volume and level:51 (leg) 
Tibial tubercle= 0.814 
4-cm from tibial tubercle=0.892 
8-cm from tibial tubercle=0.878 
Distal end=0.715 
 
Concurrent Validity: 
- water displacement r=.32,52 (leg) r=.93-.9817,27 
(arm and leg) 
- water displacement for normal limb: r=.55-.6126 
(leg) 
- water displacement affected limb: r=.75-.8026 
(leg) 
- CLEMS (computerized volume measurement 
system): r = 0.34152 (leg) 
- automated volume estimates of legs: r=0.97735 
(arm and leg) 
- with water displacement for17,26,27 (leg) 
- grade 1 lymphedema: r=0.45;  
- grade 2 lymphedema: r=0.92; 
- grade 3 lymphedema: r=0.92 
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Optoelectric 
volumetry 
ICC=0.99 (0.98 
- 0.99 CI95)18,36  
(leg) 
ICC ≥ 0.99 
(0.99 to 
1.00)37,38 
(arm) 
ICC=0.99737 
(leg) 
 
CV = .1336 Concurrent Validity: 
- water displacement r=.9733 (leg) 
- circumferential measurement with tape 
measure34 (arm) 
- r=.999 for mannequin limbs 
- r=.985 for normal human arms 
- r=.988 for upper extremity lymphedema 
- strain gauge: r=0.6334 (arm) 
- with tape measure ICC=0.99735 (arm and leg) 
- with truncated cone total limb volume r=0.9838 
(arm) 
 
Urogenital Lymphedema Measures – Recommended 
Bioimpedance  ICC= 0.95 
(0.90 to 
0.98)38 (arm) 
 
ICC = 0.8844 
(leg) 
ICC=0.8844  
(leg) 
 CV = 15.6 to 
17.222 (leg) 
 
In lymphatic filariasis44 (leg) 
- Sensitivity = 100%  
- Specificity= 21.4%  
 
Validity: 
- Bipolar and tetrapolar technique Cronbach’s 
alpha = .668 (coefficient of variability <5% 
variability in 93% of measures)45 (arm) 
- Concordance correlation with perometer r=0.9238 
(arm) 
- Concordance correlation with truncated cone 
total limb volume r=0.8938 (arm) 
 
Positive predictive value = 53.2% (lymphatic filariasis)44 
(leg) 
 
Pedal Edema:22 (leg) 
- Effect size = .64 to .93   
 
CV – coefficient of variation; ICC – intraclass correlation coefficient; P = intrasubject correlation coefficient; r – Pearson’s correlation coefficient; 
UE – upper extremity 
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Figure 1: Cancer EDGE Rating Scale 
4 Highly Recommend 
The outcome has good psychometric properties and good 
clinical utility; the measure has been used in research on 
individuals with or post cancer. 
3 Recommend 
The outcome measure has good psychometric properties 
and good clinical utility; no published evidence that the 
measure has been applied to research on individuals with 
or post cancer. 
 
2A 
Unable to 
Recommend at 
this time 
There is insufficient information to support a 
recommendation of this outcome measure; the measure 
has been used in research on individuals with or post 
cancer. 
 
2B 
Unable to 
Recommend at 
this time 
There is insufficient information to support a 
recommendation of this outcome measure; no published 
evidence that the measure has been applied to research 
on individuals with or post cancer. 
1 Do not Recommend 
Poor psychometrics &/or poor clinical utility (time, 
equipment, cost, etc.) 
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Figure 2:  Cancer EDGE Rating Scale, Updated 2016 
4 Highly Recommended 
The outcome measure has excellent psychometric 
properties (reliability and validity AND have available 
data to guide interpretation) in condition of interest and 
excellent clinical utility (≤20 min, equip in clinic, no 
copyright payments, easy to score); the measure is free 
or reasonably accessible to a broad range of providers. 
3 Recommended 
The outcome measure has good psychometric properties 
(may lack some info about reliability, validity, 
responsiveness) in the population of interest and good 
clinical utility (>20 min, some equip, training, copyright 
fee); OR has excellent psychometric properties but is not 
free and may require access to specialized testing 
equipment that is beyond the means of many clinicians or 
clinics. 
 
2 Reasonable to Use 
Limited study in target group; the outcome measure has 
good or excellent psychometric properties and clinical 
utility in a related population, but insufficient study in 
target population to support higher recommendation. 
1 Not Recommended The outcome measure has poor psychometric properties 
and/or poor clinical utility 
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Figure 3. PRISMA Flow of literature search. 
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through other sources: 
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Articles screened for 
eligibility:  
158 
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Appendix A  
Secondary search terms: 
Reliability of lymphedema 
Reliability of lower extremity 
Lower extremity lymphedema 
Lower extremity limb volume treatments 
Lymphedema treatments 
Measure AND lymphedema 
Measure AND limb volume 
Limb volume AND tape measure 
Limb volume AND volumeter 
Limb volume AND bioimpedence 
Limb volume AND ultrasound 
Limb volume AND perometer 
Limb volume AND water displacement 
 
 
